Navigation Links
Biomarkers: What can they tell us
Date:12/12/2008

SAN ANTONIO - As cancer researchers move away from the general use of chemotherapy and into more targeted approaches, scientists are working to discover effective ways to measure response and risk. Data presented at the CTRC-AACR San Antonio Breast Cancer Symposium illustrate the cutting edge of biomarker discovery and development.


Reductions in Breast Density Predict Potential Benefit of Tamoxifen
Abstract #61, Jack Cuzick, Ph.D.

A reduction in breast density of at least 10 percent may predict who benefits from the breast cancer preventive effects of tamoxifen. Researchers studied 1,063 women and found that those with reduced breast density after 12 to 18 months of treatment had a 52 percent reduced risk of breast cancer. By contrast, those women who did not have a decrease in breast density had only an eight percent risk reduction.

Full release available/Complete data to be presented at the meeting


Poor Prognosis on Small, HER2 Positive Tumors
Abstract #701, Ana M. Gonzalez-Angula, M.D

Although current guidelines call for no further therapy after surgery on breast tumors one centimeter or smaller, a new study suggests that if these tumors are HER2 positive patients have an increased risk for relapse. In the largest study of its kind to date (n=1,315, including a validation set), researchers found that the five-year recurrence rate was 23 percent among patients with small HER2-positive tumors, compared with eight percent in other tumor types.

Full release available/Complete data to be presented at the meeting


New Genetic Modeling Improves Screening
Abstract #502, Kathie Dalessandri, M.D.

A new genetic model based on 22 single nucleotide polymorphisms may improve the ability to predict risk of developing breast cancer. Researchers found that in a high-risk population from Marin County, California, this model improved diagnostic accuracy by
'/>"/>

Contact: Jeremy Moore
Jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... N Y, New York (PRWEB) November 24, 2014 ... firm, announced today that it has received national Tier recognition ... “Best Law Firms.” Achieving a tiered ranking signals a unique ... , “We are very proud to receive this honor and ... firm has made this important honor and ranking possible,” said ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has ... . They are now offered at deeply discounted prices, ... from now to Dec. 15. The main purpose of the ... company’s high quality items are ideal options for ladies who ... of money. All its new mint cocktail dresses are very ...
(Date:11/23/2014)... Vancouver, BC (PRWEB) November 23, 2014 Pro ... recently announced that it will now be providing an 8 ... number of hot water tank installations went up due to ... Care to assure its customers of the premium service that ... be offering 8 year warranty on John Wood and Bradford ...
(Date:11/23/2014)... Locks-Magnetic.com, a notable magnetic locks maker, ... the new products are available at low rates up ... proud of the new emergency doors. The emergency door ... can choose from several colors. All of the products ... door release is not as easy as many people ...
(Date:11/23/2014)... York, NY (PRWEB) November 23, 2014 ... the past month in a federal litigation involving Byetta ... similar diabetes medications, Bernstein Liebhard LLP reports. , ... 566 claims over a class of Type 2 diabetes ... filed in the U.S. District Court, Southern District of ...
Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... ... own custom branded mobile application to iPhone, iPad, and Android devices without having to hire ... ... platform that allows businesses to build and deploy their own mobile application, customizing ...
... ... that are demanding increased precision, scalability, and clarity in their system architectures. These ... as tool-customized editions for Enterprise Architect™ and MagicDraw™. , ... (PRWEB) -- PivotPoint Technology Corporation, ...
... millions of patients worldwide participate in randomized clinical trials ... help someone else with the same condition. However, ... clinical trials where resources are limited and risks may ... drugs. "There is no question that research ...
... 26, 2010 ─ (BRONX, NY) ─ Tiny, melanin-covered nanoparticles ... radiation therapy, according to scientists at Albert Einstein College ... strategy in mouse models. Infusing these particles into human ... is described in the current issue of the ...
... white rice strips vital ingredient, researchers believe , MONDAY, ... brown and half-milled rice -- may reduce the risk of ... protein linked to those conditions, research suggests., , In a ... brown rice is better than white rice when it comes ...
... mice, a team of researchers has pinpointed the location of ... of shins, and in other bones. The team also ... The research was conducted at the National Institutes of Health ... cells and some of the genetic triggers that control their ...
Cached Medicine News:Health News:Snowflake Mobile™ Launches Platform for Creating and Deploying Mobile Apps 2Health News:PivotPoint Technology Launches Advanced SysML Training Services 2Health News:PivotPoint Technology Launches Advanced SysML Training Services 3Health News:Novel nanoparticles prevent radiation damage 2Health News:Novel nanoparticles prevent radiation damage 3Health News:Novel nanoparticles prevent radiation damage 4Health News:NIH study confirms location of stem cells near cartilage-rich regions in bones 2Health News:NIH study confirms location of stem cells near cartilage-rich regions in bones 3
(Date:11/24/2014)... 24, 2014  Surgical Theater, LLC, announced today that ... th opening of Europe,s ... "C. Besta." The SuRgical Planner (SRP) and the Surgical ... event for their 3D navigation and augmented reality capabilities ... , Professor and Chair, Department of Neurosurgery at Mount ...
(Date:11/24/2014)...  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... board of directors and from his positions as chairman and ... serving as the company,s president and chief operating officer, will ... board of directors.  Gary Lyons , a member of ... Gower is expected to remain an employee until the end ...
(Date:11/24/2014)... Nov. 24, 2014  Pifflers United Chronic and ... the release of results of a study of ... the self-management of fibromyalgia pain. The results demonstrated ... pain, very significant clinically meaningful pain reduction can ... members with fibromyalgia used ActiPatch® for 7 days ...
Breaking Medicine Technology:Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 2Surgical Theater's Technology to be Showcased at the Opening of the Besta NeuroSim Center in Milan, Italy 3Rigel Announces Executive Management Changes 2Rigel Announces Executive Management Changes 3Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 2Pifflers United - "Supporting Anyone Living With Chronic/Invisible Illness" Reports ActiPatch Bioelectronic Therapy Relieves Chronic Pain In Fibromyalgia 3
... the ASSERT Trial Presented at EULAR, BARCELONA, ... today at the European League Against Rheumatism ... patients with,ankylosing spondylitis (AS) who received REMICADE(R) ... spinal,mobility. In addition, REMICADE-treated patients showed sustained,reductions ...
... from 741-patient trial show those treated with,Prexige experienced ... , * Many patients with osteoarthritis also have ... can impact,cardiovascular risk[2],[3] , * Prexige approved in ... US for use in osteoarthritis patients , BASEL, ...
Cached Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 2Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 3Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 4Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 5Prexige Study Shows Significantly Less Impact on Blood Pressure,Than Ibuprofen in Osteoarthritis Patients with Controlled,Hypertension 6
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
These retractors are packaged singly ready for sterilization at your facility....
... a revolutionary motorized electronic pipette. Conceived ... Pipetman Concept features exclusive multifunction characteristics ... one of its kind in the ... from Gilson, this product will maximize ...
... 3 - Vivid family system designed to ... cardiovascular performance, and offer an even wider ... and the OR. , ,From color flow ... connectivity, the new Vivid 3 offers a ...
Medicine Products: